China Shineway Pharmaceutical Group Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Shineway Pharmaceutical Group Limited with three other
companies in this sector in Hong Kong:
Beijing Tong Ren Tang Chinese Medicine Company Limited
sales of 1.08 billion Hong Kong Dollars [US$139.32 million]
of which 55%
was Healthcare products and Chinese medicine),
Consun Pharmaceutical Group Ltd
(1.43 billion Hong Kong Dollars [US$183.39 million]
of which 100%
was Manufacturing and sales of pharmaceutica), and
Yichang Hec Changjiang Pharmaceutical Co Ltd
(1.10 billion Hong Kong Dollars [US$141.12 million]
During the year ended December of 2016, sales at
China Shineway Pharmaceutical Group Limited were HK$2.33 billion (US$298.79 million).
decrease of 8.2%
versus 2015, when the company's sales were HK$2.53 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, China Shineway Pharmaceutical Group Limited had sales
of HK$2.39 billion.
Contributing to the drop in overall sales was the 16.2% decline
in Soft Capsules, from HK$506.02 million to HK$423.96 million.
There were also decreases in sales in
Injections (down 10.0% to HK$1.29 billion)
Granules (down 7.4% to HK$448.31 million)
However, these declines were partially offset by the increase in sales of
Others (up 51.5% to HK$158.49 million)